FindTrial
Sign In

Laser therapy in the management of Type 2 Diabetes Mellitus: a randomized health study

Photobiomodulatory Therapy in the metabolic control of Type 2 Diabetes Mellitus: randomized clinical trial - ILIB Intravascular Laser Irradiation of Blood

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4cmhfbj
Enrollment
Unknown
Registered
2024-05-22
Start date
2023-06-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2

Interventions

This is a two-arm randomized controlled clinical trial with blinding. Initially, the Basic Health Units will be randomized to define which unit will receive the intervention with protocol I (Group 1),
E02.594.540

Sponsors

Universidade Federal do Maranhão
Lead Sponsor
Universidade Federal do Maranhão
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Be aged 18 or over; both genders; have a diagnosis of type 2 diabetes mellitus; be being monitored at the Basic Health Units that are part of the study; have preserved cognitive capacity, which will be assessed using the Mini Mental State Examination (MEEN)

Exclusion criteria

Exclusion criteria: Uncontrolled diabetes, measured at the time of recruitment or via information obtained from the patient; smoker; alcoholic; insulin therapy; people with neuromuscular or musculoskeletal diseases or conditions that contraindicate photobiomodulation

Design outcomes

Primary

MeasureTime frame
We expect to find a reduction in the average values of glycemic markers.—

Secondary

MeasureTime frame
Information is expected on the effect of modified ILIB on blood metabolism, heart rate, oxygen saturation, pain level and capillary glycemia.—

Countries

Brazil

Contacts

Public ContactAndressa Jhulier Faiola Oliveira

Universidade Federal do Maranhão

andressajhulier@hotmail.com+55 (99) 3529-6055

Outcome results

None listed

Source: REBEC (via WHO ICTRP)